LabCorp Announces Full Portfolio of Hepatitis C Virus Drug Resistance Assays
May 18, 2015 at 08:45 AM EDT
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced the launch of two new Hepatitis C Virus (HCV) drug ...